Anju Sreelatha

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Google:
"Anju Sreelatha"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pon A, Osinski A, Sreelatha A. (2023) Redefining pseudokinases: A look at the untapped enzymatic potential of pseudokinases. Iubmb Life
Sreelatha A, Nolan C, Park BC, et al. (2020) A effector kinase is activated by host inositol hexakisphosphate. The Journal of Biological Chemistry
Lopez VA, Park BC, Nowak D, et al. (2019) A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity. Cell
Tomchick DR, Sreelatha A, Yee SS, et al. (2019) Protein AMPylation by an evolutionarily conserved pseudokinase Acta Crystallographica Section A. 75
Sreelatha A, Yee SS, Lopez VA, et al. (2018) Protein AMPylation by an Evolutionarily Conserved Pseudokinase. Cell
Nguyen KB, Sreelatha A, Durrant ES, et al. (2016) Phosphorylation of spore coat proteins by a family of atypical protein kinases. Proceedings of the National Academy of Sciences of the United States of America
Sreelatha A, Kinch LN, Tagliabracci VS. (2015) The secretory pathway kinases. Biochimica Et Biophysica Acta. 1854: 1687-93
Sreelatha A, Bennett TL, Carpinone EM, et al. (2015) Vibrio effector protein VopQ inhibits fusion of V-ATPase-containing membranes. Proceedings of the National Academy of Sciences of the United States of America. 112: 100-5
Lewallen DM, Sreelatha A, Dharmarajan V, et al. (2014) Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation. Acs Chemical Biology. 9: 433-42
Sreelatha A, Orth K, Starai VJ. (2013) The pore-forming bacterial effector, VopQ, halts autophagic turnover. Autophagy. 9: 2169-70
See more...